Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
Steven Grinspoon(Massachusetts General Hospital), Pamela S. Douglas(Duke University), Heather J. Ribaudo(Harvard University), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Edgar T. Overton(University of Alabama at Birmingham), Udo Hoffmann(Massachusetts General Hospital), Jorge Leon-Cruz(Harvard University), Borek Foldyna(Cancer Research And Biostatistics), Kayla Paradis(Cancer Research And Biostatistics), Sara E. Looby(Cancer Research And Biostatistics), Evelynne S. Fulda(Cancer Research And Biostatistics), Michael T. Lu(Cancer Research And Biostatistics), Patrice Desvigne‐Nickens(National Heart Lung and Blood Institute), Triin Umbleja(Harvard University), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Gerald S. Bloomfield, Jhoanna C. Roa(Cancer Research And Biostatistics), Estebán Martínez(Instituto de Salud Carlos III), Marissa R Diggs(Cancer Research And Biostatistics), Judith S. Currier, Kathleen V. Fitch(Cancer Research And Biostatistics), Sara McCallum(Cancer Research And Biostatistics), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Beverly Alston‐Smith(Cancer Research And Biostatistics), Stephen D. Wiviott, Markella V. Zanni(Harvard University Press)
Cited by 447
Related Papers
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k